Paolo Ricchi

1.9k citations
88 papers · 1.2k indexed · h-index 18
Topics
Hemoglobinopathies and Related Disorders (65 papers)Iron Metabolism and Disorders (46 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers)
Partner nations
ItalyGreeceUnited States

In The Last Decade

Paolo Ricchi

81 papers receiving 1.1k citations

Peers

Paolo Ricchi
Comparison fields: 5 of 111
  • Genetics 455
  • Hematology 390
  • Molecular Biology 218
  • Pharmacology 175
  • Oncology 150
Replace Jacques Himber with:
Jacques Himber Switzerland
Güray Saydam Türkiye
Charlotte van Kesteren Netherlands
G. Defreyn Belgium
T. Cerny Switzerland
Erica Sparkenbaugh United States
Alice A. Gibson United States
Eric E. Simon United States
Dapeng Wu China
Jumei Shi China
Paolo Ricchi relative to Jacques Himber Switzerland Jacques Himber's profile →
Citations per field
00.5×6.5×
Jacques Himber · 1×
Citations per year

Countries citing papers authored by Paolo Ricchi

Since Specialization
Citations

This map shows the geographic impact of Paolo Ricchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Ricchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Ricchi more than expected).

Fields of papers citing papers by Paolo Ricchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Ricchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Ricchi. The network helps show where Paolo Ricchi may publish in the future.

Co-authorship network of co-authors of Paolo Ricchi

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Ricchi. A scholar is included among the top collaborators of Paolo Ricchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Ricchi. Paolo Ricchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 0
5 1
6 3
7 1
8 5
9 7
10 2
11 1
12 4
13 12
14 2
15 15
16 23
17 19
18 13
19 4
20 28

About Paolo Ricchi

Paolo Ricchi is a scholar working on Genetics, Hematology and Hepatology, having authored 88 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (65 papers), Iron Metabolism and Disorders (46 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers). The work is most often cited by research in Genetics (455 citations), Hematology (390 citations) and Obstetrics and Gynecology (105 citations). Paolo Ricchi has collaborated with scholars based in Italy, Greece and United States. Frequent co-authors include Angela M. Acquaviva, Raffaele Zarrilli, Sandro Pignata, Anna Spasiano, Tiziana Di Matola, Anna Apicella, Silvia Costantini, Patrizia Cinque, Aldo Filosa and Alessia Pepe. Their work appears in journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026